Early experience of robotic axillary lymph node dissection in patients with node-positive breast cancer Jee Hyun AhnJung Min ParkHyung Seok Park Editorial 23 November 2022 Pages: 405 - 412
Circadian rhythm disrupting behaviours and cancer outcomes in breast cancer survivors: a systematic review Kelly D’cunhaYikyung ParkMarina M. Reeves Review Open access 23 November 2022 Pages: 413 - 421
The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development Abrar I. AljohaniMichael S. TossEmad A. Rakha Preclinical study Open access 22 November 2022 Pages: 423 - 435
Overexpression of POU3F2 promotes radioresistance in triple-negative breast cancer via Akt pathway activation Han ZhangJieling ZhengGuozhu Xie Preclinical study 17 February 2023 Pages: 437 - 446
Effects of preoperative magnetic resonance image on survival rates and surgical planning in breast cancer conservative surgery: randomized controlled trial (BREAST-MRI trial) Bruna Salani MotaYedda Nunes ReisJosé Roberto Filassi Clinical trial Open access 14 February 2023 Pages: 447 - 461
Clinical and pathological characterization of 158 consecutive and unselected oligometastatic breast cancers in a single institution Jean-Louis LacazeCiprian ChiraFlorence Dalenc Clinical trial 15 February 2023 Pages: 463 - 474
Does the toxicity of endocrine therapy persist into long-term survivorship?: Patient-reported outcome results from a follow-up study beyond a 10-year-survival Albertini CarmenOberguggenberger AnneBrunner Christine Clinical Trial Open access 23 November 2022 Pages: 475 - 485
A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer (TNBC) (ETCTN 8620) Monica K. MalhotraShalu PahujaShannon Puhalla Clinical trial 28 February 2023 Pages: 487 - 498
Adherence to endocrine therapy in early breast cancer in relation to Cytochrome P450 2D6 genotype: a comparison between pharmacy dispensation data and medical records Linda ThorénSara MargolinJonatan D. Lindh Clinical trial Open access 01 March 2023 Pages: 499 - 508
Estimating the incidence of breast cancer recurrence using administrative data Steven HabbousAndriana BarisicClaire Holloway Epidemiology 23 November 2022 Pages: 509 - 522
Screening behaviours, demographics, and stage at diagnosis in the publicly funded Ontario Breast Screening Program Nicholas GoldRebecca A. G. ChristensenJennifer D. Brooks Epidemiology Open access 17 February 2023 Pages: 523 - 533
Changes in mammographic density and risk of breast cancer among a diverse cohort of women undergoing mammography screening Aimilia GastouniotiEric A. CohenAnne Marie McCarthy Epidemiology 17 February 2023 Pages: 535 - 544
Treatment and outcome in metastatic lobular breast cancer in the prospective German research platform OPAL M. ThillM.-O. Zahnthe OPAL study group Epidemiology Open access 18 February 2023 Pages: 545 - 553
A specific anti-cyclin D1 intrabody represses breast cancer cell proliferation by interrupting the cyclin D1–CDK4 interaction Jialiang ZhaoYan WuGuiying Li Original Laboratory Investigation 19 February 2023 Pages: 555 - 568
Single-institution outcomes after excision of benign phyllodes tumors: low recurrence risk even with positive margins Zainab BalogunJennifer G. SteimanEmilia J. Diego Original Laboratory Investigation 20 February 2023 Pages: 569 - 572
Concordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature Chiara RossiSara FraticelliMarco Lucioni Original Laboratory Investigation Open access 21 February 2023 Pages: 573 - 582
Differential response of luminal and basal breast cancer cells to acute and chronic hypoxia Qiuyu LiuNasi LiuSylvia E. Le Dévédec Original Laboratory Investigation Open access 24 February 2023 Pages: 583 - 596
Mitigating disparities in breast cancer treatment at an academic safety-net hospital Brendin R. Beaulieu-JonesGrant ShewmakerMichael R. Cassidy Original Laboratory Investigation 24 February 2023 Pages: 597 - 606
Effective combination treatments for breast cancer inhibition by FOXM1 inhibitors with other targeted cancer drugs Valeria Sanabria GuillenYvonne ZieglerBenita S. Katzenellenbogen Original Laboratory Investigation 27 February 2023 Pages: 607 - 621
Metastatic pure invasive lobular breast cancer or metastatic mixed invasive ductal and lobular breast cancer: are they different entities? Kadri Altundag Letter to the Editor 28 February 2023 Pages: 623 - 623